PharmTech Europe News

Oct 02, 2018
By Pharmaceutical Technology Editors
Idifarma, a Spanish contract development and manufacturing organization that specialises in niche and highly potent products, that its GMP spray drying technology for highly potent drugs is now operational.
Oct 01, 2018
By Pharmaceutical Technology Editors
Researchers who are younger than 35 years with an advanced degree and working within Europe will be able to apply for the award.
Oct 01, 2018
By Pharmaceutical Technology Editors
The companies partnered to build a 500-L single-use pilot-scale plant for biologics production.
Sep 28, 2018
By Pharmaceutical Technology Editors
Vetter chose a winner from four teams that worked for three months to develop ideas for applying digital technology to injectable pharmaceuticals.
Sep 28, 2018
By Pharmaceutical Technology Editors
Specialist biopharmaceutical company, Alvotech, has announced receipt of a manufacturing license from the Icelandic Medicines Agency, applying to its biopharmaceutical facility based in Reykjavik, Iceland.
Sep 28, 2018
By Pharmaceutical Technology Editors
This pharma insight briefing from Agilent Technologies will cover the application of Raman and infrared spectroscopy for pharmaceutical quality control (QC).
Sep 28, 2018
By Pharmaceutical Technology Editors
As Europe and the United Kingdom are facing the ever-expanding shadow of Brexit, a keynote session taking place at CPhI Worldwide in Madrid will look to assess the wider implications of the UK’s exit from the European Union on the Pharma sector.
Sep 27, 2018
By Pharmaceutical Technology Editors
The company plans to lay off approximately 400 employees to support the restructuring of its R&D organization.
Sep 27, 2018
By Pharmaceutical Technology Editors
The European Medicines Agency revised the number of centrally authorized medicines for which there are concerns over Brexit-related supply disruptions.
Sep 27, 2018
By Pharmaceutical Technology Editors
The company’s biosimiliar to Amgen’s Neulasta (pegfilgrastim) received a positive opinion for marketing authorization from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP).
native1_300x100
lorem ipsum